Trial intelligence / Profile preview

Intravenous n-3 polyunsaturated fatty acids in ICD patients undergoing VT induction testing

2005-002386-37Phase 2Completed

Sponsor
Aalborg University Hospital
Start
Jul 2007
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in ventricular arrhythmia (VA) comparing Omega-3 infusion arm with Placebo infusion arm (2 arms). Primary endpoint: Inducibility of sustained ventricular tachycardia. Started Jul 2007; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

ventricular arrhythmia (VA)

Beyond the preview

Go deeper on 2005-002386-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002386-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call